Translational strategy using multiple nuclear imaging biomarkers to evaluate target engagement and early therapeutic efficacy of SAR439859, a novel selective estrogen receptor degrader.

The difference in FLT-PET imaging between combination and palbociclib alone did not reach statistical significance; however, Ki-67 IHC revealed significant differences between those 2 groups, the intensity of staining decreasing more in the combination group.

also in 111,027 other papers